Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. (Q48007469)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Rajeshwar Mookerjee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

14

Michael Trauner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

3

Arthur Kaser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

15

Detlef Schuppan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

Rajiv Jalan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Herbert Tilg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Nathan A Davies

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Felix A Offner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Stephen J Hodges

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Othmar Ludwiczek

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Heinz Zoller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Akeel Alisa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ivo Graziadei

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Christian Datz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Peter Obrist

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Wolfgang Vogel

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Roger Williams

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

419-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Cytokines in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Increased plasma interleukin-8 concentrations in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Alcoholic hepatitis--glucocorticosteroids or not?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Cytokine levels in acute alcoholic hepatitis: a sequential study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900442-7

7 January 2021

10.1016/S0168-8278(02)00442-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12663232%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference